Katharina T.
- Country
- Germany
- Department
- na
Research Overview
- Phase III Randomized, Double‑Blind, Placebo‑Controlled Study of Elecoglipron in Adults with Obesity or Overweight, With or Without Type 2 Diabetes Mellitus
- Evaluation of Dapagliflozin and Lifestyle Intervention on Complication Risk in Prediabetes with Early Chronic Kidney Disease: A Randomized, Placebo-Controlled Trial
- Evaluation of Controlled-Ileal-Release Nicotinic Acid for Remission Induction in Prediabetes: A Phase II Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 6 of 67 partner sites.
Specializations
Hematologic Oncology
The investigator concentrates on malignant blood disorders, emphasizing risk‑adapted therapeutic strategies.
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Acute Lymphoblastic Leukemia
Clinical activity includes evaluation of novel agents for refractory disease and transplantation‑related outcomes.
Solid Tumor Oncology
Research targets a broad spectrum of epithelial malignancies with an emphasis on molecularly defined subgroups.
- Breast Cancer
- Non‑Small Cell Lung Cancer
- Gastroesophageal Adenocarcinoma
- Head and Neck Squamous Cell Carcinoma
- Colorectal Cancer
Investigations explore immunotherapy combinations and biomarker‑driven treatment selection.
Neurodegenerative and Neurological Disorders
Focus is placed on progressive neurodegenerative conditions where disease‑modifying approaches are needed.
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Parkinson’s Disease
- Multiple Sclerosis
- Vascular Dementia
Clinical programs assess symptomatic relief and neuroprotective interventions.
Metabolic and Nutritional Medicine
Investigations address metabolic dysregulation and nutrient deficiencies impacting systemic health.
- Prediabetes
- Severe Vitamin D Deficiency
- Obesity‑Related Metabolic Syndrome
- Type 2 Diabetes
- Nutrition‑Driven Immune Modulation
Trials evaluate dietary interventions and metabolic‑targeted pharmacotherapy.
Immunology and Autoimmune Conditions
Efforts are directed toward immune‑mediated skin and systemic diseases.
- Atopic Dermatitis
- Chronic Spontaneous Urticaria
- Autoimmune Bullous Dermatoses
- Hidradenitis Suppurativa
- Allergic Rhinitis
Research includes biologic agents and precision‑medicine strategies for disease control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.